CA-VISA
Visa Inc. (NYSE: V) today announced that Kelly Mahon Tullier will join the company as Executive Vice President and Deputy General Counsel, effective June 16. She will also serve as a member of the company’s Executive Committee. Ms. Tullier will transition to the role of Executive Vice President and General Counsel on October 1, 2014. She joins Visa from PepsiCo, Inc., where she was the Senior Vice President and Deputy General Counsel.
Ellen Richey, Chief Legal Officer, Chief Risk Officer, and member of the Executive Committee will continue in those roles through September 30, when she will become Vice Chairman – Risk and Public Policy. The Chief Risk Officer and the Chief Audit Executive will report directly to Ms. Richey. Ms. Richey will also lead a newly created function responsible for Public Policy at Visa, which will include ensuring that Visa continues to drive the future of payment security, being our voice with legislators, regulators and clients globally regarding payment system security, and other similar initiatives combining business and policy issues of strategic importance to Visa. She will also be responsible for coordinating global crisis management at the executive level.
“We are thrilled to have Kelly join the Visa team and to create the opportunity for Ellen to guide us through this critical time in the evolution of the payment system,” said Charlie Scharf, Visa’s CEO. “Kelly’s extensive global and broad leadership experience will be a great complement to our outstanding legal team.”
“I have extraordinary respect for Ellen,” Charlie added. “She has helped Visa navigate through many complex issues in her Legal and Risk roles. Her deep expertise and judgment, both at Visa and elsewhere, are invaluable and make her the ideal person to lead global risk management and help us further develop our public policy strategies.”
Ms. Tullier has been the PepsiCo, Inc. Senior Vice President and Deputy General Counsel, managing the global legal teams supporting the businesses around the world, and centralized teams responsible for mergers and acquisitions, intellectual property, regulatory, litigation, environmental, and procurement legal work. Prior to that role, she was Senior Vice President and General Counsel for PepsiCo’s Asia, Middle East & Africa Sector, based in Dubai, where she managed legal issues in over 70 countries, including the important growth markets of China and India. Prior to that, she was Vice President and General Counsel at Frito-Lay, Inc., with responsibility for a wide range of legal, policy and compliance issues. Earlier in her career, she was an associate at Baker Botts LLP. Ms. Tullier received a B.A. from Louisiana State University and her J.D., magna cum laude , from Cornell Law School. She also served as law clerk to the Honorable Sidney A. Fitzwater, U.S. District Court, Northern District of Texas.
Prior to joining Visa Inc., Ms. Richey worked at Washington Mutual Inc. as Senior Vice President of Enterprise Risk Management and Executive Vice President of Cards Services, from October 2005 to June 2006. Before that, she served as Vice Chairman of Providian Financial Corporation, where she had responsibility for enterprise risk management, legal and regulatory affairs, corporate governance and corporate relations, as well as the compliance and audit functions of the company. Earlier in her career, Ms. Richey was a Partner in the San Francisco law firm Farella, Brown & Martel, where she specialized in corporate, real estate and financial institution matters. Ms. Richey received a B.A. in Linguistics and Far Eastern languages from Harvard University and a J.D. from Stanford Law School. She also served as a law clerk for Judge Charles B. Renfrew of the U.S. District Court for the Northern District of California and for Associate Justice Lewis F. Powell, Jr., of the United States Supreme Court.
About Visa Inc. : Visa is a global payments technology company that connects consumers, businesses, financial institutions, and governments in more than 200 countries and territories to fast, secure and reliable electronic payments. We operate one of the world’s most advanced processing networks — VisaNet — that is capable of handling more than 30,000 transaction messages a second, with fraud protection for consumers and assured payment for merchants. Visa is not a bank and does not issue cards, extend credit or set rates and fees for consumers. Visa’s innovations, however, enable its financial institution customers to offer consumers more choices: pay now with debit, ahead of time with prepaid or later with credit products. For more information, visit corporate.visa.com .
Contact:
Visa Inc.
Rosetta Jones, +1 704-444-3815
rjones@visa.com
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum